NIGHTINGALE HEALTH EO 1 (7XE) — Cash Flow-to-Debt Ratio
NIGHTINGALE HEALTH EO 1 (7XE) has a Cash Flow-to-Debt Ratio of -1.21x as of June 2025, meaning its operating cash flow of €-10.11 Million could theoretically repay -1% of its total liabilities (€8.35 Million) in one year. Explore 7XE cash flow metrics to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NIGHTINGALE HEALTH EO 1 Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for NIGHTINGALE HEALTH EO 1 across 4 annual periods. Also explore NIGHTINGALE HEALTH EO 1 asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for NIGHTINGALE HEALTH EO 1 (2022–2025)
Year-by-year debt coverage analysis for NIGHTINGALE HEALTH EO 1. For market capitalisation and broader financial context, see 7XE stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.21x | €-10.11 Million | €8.35 Million | ▼ -14.6% |
| 2024 | -1.06x | €-8.41 Million | €7.96 Million | ▼ -36.0% |
| 2023 | -0.78x | €-7.33 Million | €9.44 Million | ▼ -31.0% |
| 2022 | -0.59x | €-7.47 Million | €12.61 Million | — |